Review article · 2026 · Open access
Extracellular Vesicles in Cancer: Biomarkers, Mechanisms, and Emerging Diagnostic Technologies
Advanced Healthcare Materials, 15(32), e71462 · Published 26 July 2026 · DOI 10.1002/adhm.71462
In brief
“Extracellular Vesicles in Cancer: Biomarkers, Mechanisms, and Emerging Diagnostic Technologies” is a 2026 review article by Cheng Wang and 4 co-authors, published in Advanced Healthcare Materials. OpenAlex counts 0 citations as of 15 November 2026. It is open access: the full text is free to read at PubMed Central.
- Citations
- 0
- References
- 229
- Authors
- 5
Abstract
Extracellular vesicles (EVs) are nanoscale, membrane-bound particles that transport diverse biomolecules-including proteins, nucleic acids, lipids, and metabolites-between cells, thereby orchestrating key processes in cancer progression. Tumor-derived EVs modulate angiogenesis, epithelial-to-mesenchymal transition, extracellular matrix remodeling, fibroblast activation, and immune evasion, shaping the tumor microenvironment, and driving metastasis as well as therapy resistance. With their stability in biofluids and cargo reflective of cellular origin, EVs have emerged as powerful non-invasive biomarkers for early detection, disease monitoring, and prognosis across multiple cancer types. Recent advances in enrichment, characterization, and molecular profiling technologies-ranging from ultracentrifugation and microfluidics to proteomics, RNA sequencing, and surface-enhanced Raman spectroscopy, have greatly expanded the diagnostic potential of EVs. Integration with machine learning further enhances sensitivity, specificity, and tumor classification, while multiomic and multiplex platforms enable high-throughput and clinically relevant applications. This review highlights the multifaceted roles of EVs in cancer biology, catalogs emerging biomarkers, and compares state-of-the-art detection technologies, offering a comprehensive reference for advancing EV-based diagnostics and precision oncology.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Wang, C., Peng, J., Xie, S., Kang, C., & Liu, Y. (2026). Extracellular Vesicles in Cancer: Biomarkers, Mechanisms, and Emerging Diagnostic Technologies. Advanced Healthcare Materials, 15(32), e71462. https://doi.org/10.1002/adhm.71462
MLA 9
Wang, Cheng, et al. “Extracellular Vesicles in Cancer: Biomarkers, Mechanisms, and Emerging Diagnostic Technologies.” Advanced Healthcare Materials, vol. 15, no. 32, 2026, p. e71462. https://doi.org/10.1002/adhm.71462.
Chicago
Wang, Cheng, Juan Peng, Sichong Xie, Chao Kang, and Yajuan Liu. 2026. “Extracellular Vesicles in Cancer: Biomarkers, Mechanisms, and Emerging Diagnostic Technologies.” Advanced Healthcare Materials 15 (32): e71462. https://doi.org/10.1002/adhm.71462.
Harvard
Wang, C. et al. (2026) ‘Extracellular Vesicles in Cancer: Biomarkers, Mechanisms, and Emerging Diagnostic Technologies’, Advanced Healthcare Materials, 15(32), p. e71462. doi:10.1002/adhm.71462.
IEEE
C. Wang, J. Peng, S. Xie, C. Kang, and Y. Liu, “Extracellular Vesicles in Cancer: Biomarkers, Mechanisms, and Emerging Diagnostic Technologies,” Advanced Healthcare Materials, vol. 15, no. 32, p. e71462, 2026, doi: 10.1002/adhm.71462.
BibTeX
@article{wang2026extracellular,
title = {{Extracellular Vesicles in Cancer: Biomarkers, Mechanisms, and Emerging Diagnostic Technologies}},
author = {Wang, Cheng and Peng, Juan and Xie, Sichong and Kang, Chao and Liu, Yajuan},
journal = {Advanced Healthcare Materials},
year = {2026},
volume = {15},
number = {32},
pages = {e71462},
doi = {10.1002/adhm.71462},
url = {https://doi.org/10.1002/adhm.71462}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- extracellular vesicles
- cancer
- tumor markers
- tumor microenvironment
- metastasis
- treatment resistance
- EV-based diagnostics
- EV isolation and characterization
Work with this paper
Most-cited papers in Biochemistry, Genetics and Molecular Biology
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTOliver H. Lowry, NiraJ. Rosebrough, A. Lewis Farr and 1 more · Journal of Biological Chemistry · 1951 · 316,470 citations
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingM Bradford · Analytical Biochemistry · 1976 · 256,780 citations
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodKenneth J. Livak, Thomas D. Schmittgen · Methods · 2001 · 184,418 citations
- Molecular Cloning: A Laboratory ManualJoseph Sambrook, Elisabeth Fritsch, Tom Maniatis · UCLA - Biblioteca de Ciencias de la Salud · 1989 · 133,493 citations
- Basic Local Alignment Search ToolStephen F. Altschul, Warren R. Gish, Webb Miller and 2 more · Journal of Molecular Biology · 1990 · 100,529 citations
All highly cited Biochemistry, Genetics and Molecular Biology papers
Questions about this paper
How do I cite this paper in APA style?
Wang, C., Peng, J., Xie, S., Kang, C., & Liu, Y. (2026). Extracellular Vesicles in Cancer: Biomarkers, Mechanisms, and Emerging Diagnostic Technologies. Advanced Healthcare Materials, 15(32), e71462. https://doi.org/10.1002/adhm.71462
How many times has this paper been cited?
0 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at PubMed Central.
Who wrote this paper?
Cheng Wang, Juan Peng, Sichong Xie, Chao Kang, Yajuan Liu.
What is the DOI of this paper?
10.1002/adhm.71462. The permanent link is https://doi.org/10.1002/adhm.71462.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.